is a medication that stimulates the process of erythrocytes production (erythropoiesis) by the hematopoietic tissue of the bone marrow. It is used to treat anemia in patient with chronic kidney disease or those who require dialysis in patients who is treated from cancer by chemotherapy and radiation in HIV patients who takes Zidovudine. Epocrin increases hemoglobin and hematocrit levels, improves blood supply of tissues and enhances the heart functioning.
100% Original from the Russian LLC Rusbiomed.
All packs are air tight sealed and expire up to 06.2021.
Epocrin includes the active substance - Epoetin alfa - which is a synthetic analog of human erythropoietin and has the same biological activity as the endogenous hormone. It is produced in cell culture using recombinant DNA technology. Epocrin stimulates the division and differentiation of committed erythroid progenitor cells by binding to the erythropoietin receptor, which activates JAK-STAT signaling pathways within the cytosol. It induces the bone marrow to release reticulocytes into the blood stream, where they mature to erythrocytes.
Epocrin comes in the form of a solution for injection at a dosage of 400 UI/ml. Active substance: epoetin alfa.
Epocrin is administered intravenously or subcutaneously.
Anemia caused by chronic renal failure: initial dose - 50-100 units/kg of body weight 3 times/week.
Anemia in cancer patients on chemotherapy: initial dose - 150 units/kg subcutaneously 3 times/week.
Anemia in HIV patients treated by zidovudine: initial dose - 100 units/kg intravenously or subcutaneously 3 times/week for eight weeks.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place. Do not exceed storage temperature of 2-8 degrees Celcius. Do not freeze. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Epocrin.
|The purpose of the medication||Blood and Circulatory Treatment|